Business Description
Acorda Therapeutics Inc
NAICS : 325414
SIC : 2836
ISIN : US00484M1062
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.37 | |||||
Equity-to-Asset | 0.51 | |||||
Debt-to-Equity | 0.22 | |||||
Debt-to-EBITDA | -0.26 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -33.04 | |||||
Beneish M-Score | -3.35 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -37 | |||||
3-Year EBITDA Growth Rate | -28.4 | |||||
3-Year EPS without NRI Growth Rate | 48.1 | |||||
3-Year FCF Growth Rate | 58.6 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 32.23 | |||||
9-Day RSI | 33.53 | |||||
14-Day RSI | 32.83 | |||||
6-1 Month Momentum % | -99.21 | |||||
12-1 Month Momentum % | -99.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.82 | |||||
Quick Ratio | 1.79 | |||||
Cash Ratio | 0.98 | |||||
Days Inventory | 514.55 | |||||
Days Sales Outstanding | 59.24 | |||||
Days Payable | 346.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -37.9 | |||||
Shareholder Yield % | -28535.29 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 87.54 | |||||
Operating Margin % | -7.72 | |||||
Net Margin % | -320.09 | |||||
FCF Margin % | -37.47 | |||||
ROE % | -1800.75 | |||||
ROA % | -78.69 | |||||
ROIC % | -1.52 | |||||
3-Year ROIIC % | -21.18 | |||||
ROC (Joel Greenblatt) % | -2506.37 | |||||
ROCE % | -137.6 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.15 | |||||
EV-to-EBITDA | -0.16 | |||||
EV-to-Revenue | 0.54 | |||||
EV-to-FCF | -1.44 | |||||
Earnings Yield (Greenblatt) % | -666.67 | |||||
FCF Yield % | -159711.76 | |||||
Forward Rate of Return (Yacktman) % | -1964290.09 |